Financials Medtecs International Corporation Limited

Equities

546

BMG5958R1043

Medical Equipment, Supplies & Distribution

Market Closed - Singapore S.E. 05:04:34 2024-04-26 am EDT 5-day change 1st Jan Change
0.129 SGD -0.77% Intraday chart for Medtecs International Corporation Limited +0.78% -30.65%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 10.86 15.1 416 141.8 81.34 76.84
Enterprise Value (EV) 1 43.47 55.93 370.5 108.8 66.45 76.08
P/E ratio 11.9 x 13 x 3.16 x 8.18 x -2.85 x -3.65 x
Yield - - 6.64% 2.31% - -
Capitalization / Revenue 0.16 x 0.22 x 1.04 x 0.98 x 1.45 x 1.46 x
EV / Revenue 0.64 x 0.81 x 0.93 x 0.76 x 1.18 x 1.45 x
EV / EBITDA 8.6 x 10.5 x 2.64 x 5.53 x -2.23 x -3.66 x
EV / FCF -46.4 x -10.7 x 9.11 x 15.9 x -17.2 x -8.43 x
FCF Yield -2.16% -9.37% 11% 6.31% -5.8% -11.9%
Price to Book 0.17 x 0.24 x 2.15 x 0.76 x 0.54 x 0.59 x
Nbr of stocks (in thousands) 549,411 549,411 549,411 546,411 544,911 544,911
Reference price 2 0.0198 0.0275 0.7572 0.2595 0.1493 0.1410
Announcement Date 4/3/19 4/15/20 4/13/21 4/15/22 6/15/23 4/14/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 68.3 68.98 400.3 144.2 56.24 52.64
EBITDA 1 5.053 5.327 140.2 19.69 -29.78 -20.76
EBIT 1 2.624 3.035 136.2 16.01 -33.07 -24.99
Operating Margin 3.84% 4.4% 34.02% 11.11% -58.8% -47.47%
Earnings before Tax (EBT) 1 1.186 1.517 135.1 16.92 -30.65 -22.52
Net income 1 0.914 1.162 131.7 17.34 -28.6 -21.07
Net margin 1.34% 1.68% 32.9% 12.03% -50.84% -40.02%
EPS 2 0.001659 0.002109 0.2397 0.0317 -0.0524 -0.0387
Free Cash Flow 1 -0.9371 -5.238 40.69 6.862 -3.856 -9.03
FCF margin -1.37% -7.59% 10.16% 4.76% -6.86% -17.15%
FCF Conversion (EBITDA) - - 29.03% 34.85% - -
FCF Conversion (Net income) - - 30.89% 39.57% - -
Dividend per Share - - 0.0503 0.006000 - -
Announcement Date 4/3/19 4/15/20 4/13/21 4/15/22 6/15/23 4/14/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 32.6 40.8 - - - -
Net Cash position 1 - - 45.5 32.9 14.9 0.76
Leverage (Debt/EBITDA) 6.453 x 7.665 x - - - -
Free Cash Flow 1 -0.94 -5.24 40.7 6.86 -3.86 -9.03
ROE (net income / shareholders' equity) 1.45% 1.82% 102% 8.64% -17.2% -15.9%
ROA (Net income/ Total Assets) 1.47% 1.65% 47% 4.34% -10.4% -8.96%
Assets 1 61.98 70.29 280.3 399.7 275.1 235.2
Book Value Per Share 2 0.1100 0.1200 0.3500 0.3400 0.2700 0.2400
Cash Flow per Share 2 0.0100 0.0100 0.1500 0.0900 0.0300 0.0400
Capex 1 5.31 4.57 8.4 16.4 19.8 4.89
Capex / Sales 7.77% 6.63% 2.1% 11.36% 35.17% 9.29%
Announcement Date 4/3/19 4/15/20 4/13/21 4/15/22 6/15/23 4/14/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 546 Stock
  4. Financials Medtecs International Corporation Limited